A Sharp Rise in Autoimmune Encephalitis in the COVID-19 Era: A Case Series.

Saffari, Pardis; Aliakbar, Raya; Haritounian, Argin; Mughnetsyan, Rafik; Do, Catherine; Jacobs, Jamie; Hoffer, Julia; Arieli, Robert; Liu, Antonio K

Saffari, Pardis; Aliakbar, Raya; Haritounian, Argin; Mughnetsyan, Rafik; Do, Catherine; Jacobs, Jamie; Hoffer, Julia; Arieli, Robert; Liu, Antonio K.

Afiliação

Saffari P; Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Aliakbar R; Neurology, Adventist Health White Memorial, Los Angeles, USA.
Haritounian A; Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Mughnetsyan R; Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Do C; Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Jacobs J; Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Hoffer J; Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Arieli R; Internal Medicine, Adventist Health White Memorial, Los Angeles, USA.
Liu AK; Neurology, Adventist Health White Memorial, Los Angeles, USA.

Cureus ; 15(2): e34658, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36755772

Palavras-chave

anti-glutamic acid decarboxylase; autoimmune encephalitis; covid; molecular mimicry; voltage-gated potassium channel autoimmune encephalitis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos